Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-05-22
1980-01-08
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
A61K 31505
Patent
active
041827635
ABSTRACT:
Buspirone hydrochloride is an effective anti-anxiety agent for the palliative treatment of neurotic patients in which symptoms of anxiety are predominant at doses which are without observable effect in either normal individuals or psychotic patients.
REFERENCES:
patent: 3717634 (1973-02-01), Wu et al.
patent: 3976776 (1976-08-01), Wu et al.
Wu et al., J. Med. Chem. 15, (1972), pp. 477-479.
Allen et al., Arzneim-Forsch, 24, No. 6, 917-992 (1974).
Sathancenthan et al., Current Therapeutic Research, 18, (5), 701-705 (1975).
Casten George P.
McKinney Gordon R.
Newton Roger E.
Tompkins E. Crosby
Weikel, Jr. John H.
Carnahan R. E.
Friedman Stanley J.
Mead Johnson & Company
Uloth R. H.
LandOfFree
Buspirone anti-anxiety method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Buspirone anti-anxiety method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Buspirone anti-anxiety method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1941103